About Us

We provide highly specialized genetic testing to clinicians and their patients.

DNA sequencing on its own is a solved problem. Whole genome sequencing (WGS) provides a readout of a patient’s entire DNA at a lower cost every year. The challenge today is how to accurately and economically make sense of the vast amounts of data that it generates - essentially finding the needle in the haystack.

We have assembled an interdisciplinary team of talented medical professionals, bioinformaticians, software engineers, information technology and operations professionals. Together we have developed a clinical platform built and optimized for WGS data analysis, interpretation and reporting. The platform uniquely identifies a wide range of difficult-to-detect sequence variants including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions.

Our team of specially trained variant scientists and medical directors has solved hundreds of previously undiagnosed cases for rare disease patients as well as provided important information about disease predisposition risk and carrier status to healthy individuals. We are leading the way to routine, comprehensive genetic testing one patient at a time.

Meet Our Management Team

CEO

Haim Neerman

CEO
 

> Full Bio  

CSO

Noam Shomron PhD

CSO
 

> Full Bio 

CCO

Muthu Meyyappan PhD

CCO
 

> Full Bio 

CDCG

Christine Stanley PhD, FACMG

Chief Director Clinical Genomics

> Full Bio 

CIO

Yaron Rachmany

CIO
 

> Full Bio 

VPM

Jennifer Hogan PhD

VP Marketing
 

> Full Bio 

COO

Tomer Jackman

COO
 

> Full Bio 

VPR

Daryl Spinner PhD

VP Market Access and Reimbursement

> Full Bio 

Investors

Scroll Up